How to Switch from Ozempic to Compounded Semaglutide (Save $800+/Month)
Switching from Ozempic to compounded semaglutide is straightforward — same molecule, no washout, no restarting your dose. This step-by-step guide covers everything you need to make the switch and save over $800 per month.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. This guide covers the complete process for switching from Ozempic (or Wegovy, Mounjaro, or Zepbound) to compounded alternatives through Trimi — with no washout, no restarting doses, and no gap in treatment.
Quick links: Compounded semaglutide $99/mo, Compounded tirzepatide $125/mo, and Ozempic alternative overview.
More on Switching GLP-1 Providers
Ozempic Alternative for $99/Month
Full overview of compounded semaglutide versus Ozempic.
Why Is Compounded Semaglutide So Cheap?
The economics behind $99 semaglutide.
Semaglutide Without a Doctor Visit
How telehealth prescriptions work and why they are valid.
Get a Semaglutide Prescription Today
Same-day online consultation — how fast the process is.
Why So Many Patients Are Switching
Ozempic's list price of $900 to $1,100 per month is unsustainable for most patients without insurance coverage for the medication. Many patients begin Ozempic with insurance covering some or all of the cost, only to face coverage denials at the next plan year, exhausted deductibles, or employers changing formularies. Others lose coverage entirely when jobs change. When coverage disappears, the full retail price hits immediately.
The switch to compounded semaglutide is driven by a simple calculation: the same active molecule, the same clinical benefit, at $99 per month instead of $1,000 per month. Patients who are three months into Ozempic treatment and seeing results do not want to stop — they want to maintain their progress. Switching to compounded semaglutide lets them do exactly that without the financial strain.
The same switch applies to patients on Wegovy ($1,349/month), Mounjaro ($1,069/month), or Zepbound ($1,059/month). All four brand-name GLP-1 medications have equivalent compounded alternatives available through Trimi at $99 or $125 per month. The switching process is identical for all four.
Monthly savings by switching:
- Ozempic ($1,000) → Compounded semaglutide ($99) = $901/month savings
- Wegovy ($1,349) → Compounded semaglutide ($99) = $1,250/month savings
- Mounjaro ($1,069) → Compounded tirzepatide ($125) = $944/month savings
- Zepbound ($1,059) → Compounded tirzepatide ($125) = $934/month savings
The Pharmacology of Switching: Why It Is Seamless
The reason switching from Ozempic to compounded semaglutide requires no washout period and no dose restart is straightforward pharmacology. Both contain the same active molecule — semaglutide — and your body cannot tell the difference between semaglutide from a Novo Nordisk manufacturing facility and semaglutide from an accredited compounding pharmacy.
When you take your last Ozempic dose and then take your first compounded semaglutide dose at the same interval (one week later), the pharmacokinetics are identical. The same molecule is absorbed, distributed, metabolized, and excreted at the same rate. The GLP-1 receptor binding and downstream appetite suppression effects are continuous. There is no pharmacological "restart" — just continuity.
This is meaningfully different from switching between different active molecules — for example, switching from semaglutide to tirzepatide, which would involve different receptor profiles and might warrant more careful dose management. Switching between brand-name and compounded versions of the same molecule is pharmacologically equivalent to switching between two generic versions of the same drug.
Step-by-Step: How to Switch from Ozempic to Compounded Semaglutide
Know your current Ozempic dose
Before starting the switch, identify exactly what dose you are currently taking. Ozempic doses are 0.25mg, 0.5mg, 1mg, or 2mg per week. Check your pen label or your prescription record. Your compounded semaglutide will be prescribed at the equivalent dose.
Note when your last Ozempic dose was injected
Ozempic is a once-weekly injection. Knowing the date of your most recent injection tells you when your next dose is due. Your first compounded semaglutide dose should be injected at the same interval — one week after your last Ozempic dose. This ensures continuous treatment with no gap.
Important: Do not take an extra Ozempic dose and your compounded semaglutide dose in the same week. Maintain the weekly injection schedule throughout the transition.
Complete Trimi's online health assessment
Go to trytrimi.com and complete the online health assessment. You will answer questions about your medical history, current medications, weight history, and goals. Include your current Ozempic dose and injection frequency. The assessment takes 10 to 15 minutes.
Provider review and prescription
A board-certified Trimi physician reviews your submission within 24 hours on business days. They evaluate your eligibility, confirm your current dose, and prescribe compounded semaglutide at the equivalent concentration. They may also recommend adjusting your dose if clinically appropriate.
Receive your medication — time it before your supply runs out
Pharmacy preparation and shipping takes 5 to 7 business days after approval. Start the Trimi process while you still have at least 2 to 3 weeks of Ozempic supply remaining. This ensures your compounded semaglutide arrives before you need to start using it, preventing any treatment gap.
Pro tip: Many patients start the Trimi process immediately after their current Ozempic pen runs out if they are not continuing, or 2–3 weeks before it runs out if they want uninterrupted continuity.
Inject your first dose of compounded semaglutide
On the day of your next scheduled weekly injection, inject compounded semaglutide at your prescribed dose. Follow the injection instructions provided. The injection sites are the same as with Ozempic: subcutaneous injection in the abdomen (2 inches from the navel), outer thigh, or upper arm. Rotate sites with each injection.
Stop filling your Ozempic prescription
Once your compounded semaglutide is in hand and you are on schedule, simply stop filling your Ozempic prescription. No formal cancellation is required. Your Trimi subscription handles automatic monthly refills at the same dose until you and your provider decide to adjust.
Practical Differences: What Changes When You Switch
Most of your experience with semaglutide treatment will be identical after switching. The weight loss mechanism, appetite suppression, weekly injection schedule, and side effect profile are unchanged. Here are the practical differences to be aware of:
Injection device
Ozempic uses a pre-filled FlexTouch pen with a hidden needle mechanism. Compounded semaglutide comes in a vial — you draw the prescribed volume into a syringe (typically an insulin syringe) and inject. This is slightly more involved than an auto-injector but straightforward once practiced. Trimi provides detailed step-by-step injection instructions with your first order.
Storage
Both Ozempic and compounded semaglutide require refrigeration between 36°F and 46°F (2°C to 8°C). Compounded semaglutide should not be frozen. Refrigerated vials should be used within the pharmacy's labeled beyond-use date, which is typically 28 to 90 days depending on the formulation. Trimi's pharmacies include clear storage instructions with each shipment.
Monthly supply cadence
Ozempic comes in pens with multiple doses. Trimi ships compounded semaglutide monthly with the appropriate volume for your dose. Your supply arrives automatically each month — you do not need to actively reorder.
Provider relationship
Your Trimi subscription includes ongoing provider access for dose adjustments, side effect questions, and clinical guidance. This replaces whatever provider relationship you had for Ozempic. If your original Ozempic prescription was for type 2 diabetes management, inform that provider of your switch — they may want to continue monitoring your blood glucose.
Switching from Wegovy, Mounjaro, or Zepbound
The switching process described above applies equally to patients on Wegovy, Mounjaro, or Zepbound. The only difference is which Trimi product you switch to:
Ozempic → Compounded semaglutide ($99/mo)
Identical molecule, same titration schedule, same injection sites.
Wegovy → Compounded semaglutide ($99/mo)
Identical molecule at the same doses (0.25mg to 2.4mg), same weekly schedule.
Mounjaro → Compounded tirzepatide ($125/mo)
Identical dual GIP/GLP-1 agonist molecule at same doses (2.5mg to 15mg).
Zepbound → Compounded tirzepatide ($125/mo)
Identical molecule (Zepbound and Mounjaro are the same tirzepatide), same dose schedule.
For details on the tirzepatide alternatives specifically, see our guides to the Mounjaro alternative and Zepbound alternative. For the full picture of why compounding makes these prices possible, see why compounded semaglutide costs $99.
Questions Patients Ask When Switching
Patients considering the switch often have questions that go beyond the mechanics. Here are the most common:
Do I need to tell my doctor I'm switching?
If your original Ozempic prescription was for weight management by a primary care physician or obesity specialist, you are not obligated to notify them, though professional courtesy suggests you might. If your Ozempic was prescribed for type 2 diabetes management, you should inform your prescribing physician — they need to know your diabetes management plan is changing and may want to monitor your blood sugar more closely or adjust other diabetes medications.
Is the switch permanent?
There is no reason it needs to be. Some patients switch to compounded semaglutide for cost reasons and later return to Ozempic or Wegovy if their insurance coverage improves. Others switch permanently. The same seamless switching process works in both directions — you can move between brand-name and compounded versions as your situation changes.
Will my pharmacist notice if I stop filling Ozempic?
Your pharmacy may contact you if you normally refill on a schedule, but stopping is your prerogative. You are not contractually obligated to continue filling a prescription. Simply stop requesting refills — no notification to the pharmacy is required.
What if I have complications during the switch?
Complications are not expected during the switch because you are continuing the same molecule without interruption. If you experience any change in side effects or unexpected reactions, contact your Trimi provider immediately. Provider access is included in your monthly subscription.
Frequently Asked Questions
Can I switch from Ozempic to compounded semaglutide without restarting my dose?
Yes. Since both Ozempic and compounded semaglutide contain the same active molecule — semaglutide — there is no pharmacological reason to restart the titration schedule. You simply continue at your current dose with the compounded version at your next scheduled injection. Your Trimi provider will prescribe the equivalent compounded dose based on where you are in the Ozempic titration sequence.
Do I need my original Ozempic prescription to switch to Trimi?
No. Trimi conducts an independent telehealth consultation. You do not need to transfer your Ozempic prescription, obtain records from your current provider, or have any prior documentation. You simply complete Trimi's online health assessment — including your current Ozempic dose and how long you have been on it — and a Trimi physician will prescribe compounded semaglutide at the appropriate dose.
How long does it take to get compounded semaglutide after switching?
From starting the Trimi health assessment to receiving your first compounded semaglutide shipment typically takes 10 to 14 days: 24 hours for provider review, then 5 to 7 business days for pharmacy preparation and shipping. Plan this timeline before your last Ozempic dose runs out so you do not experience a gap in treatment.
Is there any difference in how compounded semaglutide is injected compared to Ozempic?
The main practical difference is the delivery device. Ozempic uses Novo Nordisk's FlexTouch auto-injector pen, which conceals the needle and makes the injection process very straightforward. Compounded semaglutide is delivered in a vial with a separate syringe. You draw the dose from the vial and inject subcutaneously in the same locations — abdomen, thigh, or upper arm. Most patients adapt within one or two injections. Trimi provides detailed instructions and your provider is available for questions.
Will I lose the same amount of weight with compounded semaglutide as with Ozempic?
Yes, because the active molecule is identical. The weight loss results documented in clinical trials are properties of the semaglutide molecule — not Novo Nordisk's manufacturing process, auto-injector device, or brand name. Your appetite suppression, weight loss progression, and side effect profile should be equivalent after switching. Many patients report no subjective difference in efficacy.
What happens to my Ozempic prescription when I switch to Trimi?
You simply stop filling your Ozempic prescription. You do not need to formally cancel it, notify your prescribing physician, or take any administrative action. Trimi is an independent telehealth provider — your Trimi prescription for compounded semaglutide is entirely separate from any prior prescriptions. If your original physician prescribed Ozempic for diabetes management (not weight loss), you should inform them of your switch, as they may want to monitor your blood glucose management.
Can I switch from Wegovy, Mounjaro, or Zepbound to compounded versions through Trimi as well?
Yes. Trimi offers compounded semaglutide (the same molecule as Ozempic and Wegovy) and compounded tirzepatide (the same molecule as Mounjaro and Zepbound). The switching process is the same for all four brand-name medications — continue at your current dose with no washout period required. Compounded semaglutide starts at $99 per month and compounded tirzepatide at $125 per month.
Sources & References
- Wilding JPH et al. STEP 1: Once-weekly semaglutide in adults with overweight or obesity. NEJM, 2021.
- Ozempic FDA prescribing information, 2023.
- Wegovy FDA prescribing information, 2023.
- FDA: Compounding and FDA — Questions and Answers.
- NABP compounding pharmacy accreditation standards.
- NIDDK: Prescription medications for overweight and obesity.
- Jastreboff AM et al. SURMOUNT-1: Tirzepatide for the treatment of obesity. NEJM, 2022.
- FDA drug shortage database.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before changing any medication or treatment plan. If you take semaglutide or tirzepatide for type 2 diabetes management, inform your endocrinologist or primary care physician before switching providers. Trimi provides compounded GLP-1 medications through licensed telehealth physicians.